Steven Schutzer from Rutgers New Jersey Medical School is leading a team assessing new vaccine strategies for Lyme disease, including a hybrid approach that can deliver a one-two punch to the microbe that causes the disease and its tick carrier. Learn more.
Recent Posts
- Join NJ ACTS Workforce Development Core for an NIH Fellowship Grant Writing Workshop this Fall
- NJACTS Community Engagement Core COVID-19 Resources
- NJACTS Community Engagement Core Available Services
- Unveiling the Biomechanical Forces that Drive Scarring.
- Scientists Discover Class of Crystals With Properties That May Prove Revolutionary.
Categories
- Community (2,291)
- Covid (988)
- CTO Events (6)
- News (2,917)
- Pilots (21)